Literature DB >> 26490383

FGF21 Revolutions: Recent Advances Illuminating FGF21 Biology and Medicinal Properties.

Alexei Kharitonenkov1, Richard DiMarchi2.   

Abstract

The biology of fibroblast growth factor 21 (FGF21) has evolved through its first decade at a revolutionary pace with dramatic refinements in this relatively short span of time. This field is poised now with a deeper understanding of its specific physiological role, pathological ramifications for its inappropriate function, and a much-enriched context of the complex hormonal network in which it serves to regulate metabolism. As a derivative of these discoveries, the application of FGF21 as a medicinal agent has emerged with structurally optimized protein-based analogs being preclinically explored in multiple species, and, more recently, through clinical studies. These novel findings set a foundation for ongoing inquiries that structure future research into this intriguing protein. Published by Elsevier Ltd.

Entities:  

Keywords:  FGF21; FGFR; KLB; drug development; hormones; metabolic regulation

Mesh:

Substances:

Year:  2015        PMID: 26490383     DOI: 10.1016/j.tem.2015.09.007

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  49 in total

1.  FGF21 Attenuates High-Fat Diet-Induced Cognitive Impairment via Metabolic Regulation and Anti-inflammation of Obese Mice.

Authors:  Qingzhi Wang; Jing Yuan; Zhanyang Yu; Li Lin; Yinghua Jiang; Zeyuan Cao; Pengwei Zhuang; Michael J Whalen; Bo Song; Xiao-Jie Wang; Xiaokun Li; Eng H Lo; Yuming Xu; Xiaoying Wang
Journal:  Mol Neurobiol       Date:  2017-07-15       Impact factor: 5.590

2.  A long-acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis partly through an FGF21-adiponectin-IL17A pathway.

Authors:  Lichen Bao; Jun Yin; Wen Gao; Qun Wang; Wenbing Yao; Xiangdong Gao
Journal:  Br J Pharmacol       Date:  2018-07-03       Impact factor: 8.739

3.  Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy?

Authors:  Stefano Benedini; Livio Luzi
Journal:  J Transl Int Med       Date:  2016-12-30

4.  Endocrine Regulator rFGF21 (Recombinant Human Fibroblast Growth Factor 21) Improves Neurological Outcomes Following Focal Ischemic Stroke of Type 2 Diabetes Mellitus Male Mice.

Authors:  Yinghua Jiang; Ning Liu; Qingzhi Wang; Zhanyang Yu; Li Lin; Jing Yuan; Shuzhen Guo; Bum Ju Ahn; Xiao-Jie Wang; Xiaokun Li; Eng H Lo; Xiaochuan Sun; Xiaoying Wang
Journal:  Stroke       Date:  2018-12       Impact factor: 7.914

Review 5.  Hepatokines-a novel group of exercise factors.

Authors:  Cora Weigert; Miriam Hoene; Peter Plomgaard
Journal:  Pflugers Arch       Date:  2018-10-18       Impact factor: 3.657

6.  Glucagon and Insulin Cooperatively Stimulate Fibroblast Growth Factor 21 Gene Transcription by Increasing the Expression of Activating Transcription Factor 4.

Authors:  Kimberly M Alonge; Gordon P Meares; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

7.  Oral administration of a new HRI activator as a new strategy to improve high-fat-diet-induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21.

Authors:  Mohammad Zarei; Eugènia Pujol; Tania Quesada-López; Francesc Villarroya; Emma Barroso; Santiago Vázquez; Javier Pizarro-Delgado; Xavier Palomer; Manuel Vázquez-Carrera
Journal:  Br J Pharmacol       Date:  2019-05-23       Impact factor: 8.739

8.  Astaxanthin attenuates hepatic damage and mitochondrial dysfunction in non-alcoholic fatty liver disease by up-regulating the FGF21/PGC-1α pathway.

Authors:  Liwei Wu; Wenhui Mo; Jiao Feng; Jingjing Li; Qiang Yu; Sainan Li; Jie Zhang; Kan Chen; Jie Ji; Weiqi Dai; Jianye Wu; Xuanfu Xu; Yuqing Mao; Chuanyong Guo
Journal:  Br J Pharmacol       Date:  2020-06-27       Impact factor: 8.739

9.  Fusion of fibroblast growth factor 21 to a thermally responsive biopolymer forms an injectable depot with sustained anti-diabetic action.

Authors:  Caslin A Gilroy; Stefan Roberts; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2018-03-15       Impact factor: 9.776

10.  A grape seed procyanidin extract inhibits HDAC activity leading to increased Pparα phosphorylation and target-gene expression.

Authors:  Laura E Downing; Bradley S Ferguson; Kelvin Rodriguez; Marie-Louise Ricketts
Journal:  Mol Nutr Food Res       Date:  2016-10-28       Impact factor: 5.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.